Citius Pharmaceuticals, Inc.
CTXR
$0.56
-$0.03-5.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.20M | -35.89M | -37.43M | -40.26M | -42.05M |
| Total Depreciation and Amortization | 2.42M | 716.40K | 214.20K | 205.90K | 217.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.19M | 10.88M | 9.61M | 9.72M | 10.46M |
| Change in Net Operating Assets | 6.99M | -10.55M | 1.05M | 9.76M | 7.82M |
| Cash from Operations | -31.60M | -34.84M | -26.55M | -20.58M | -23.55M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.75M | -10.15M | -5.75M | -5.00M | -5.00M |
| Cash from Investing | -10.75M | -10.15M | -5.75M | -5.00M | -5.00M |
| Total Debt Issued | 1.30M | 1.30M | 1.30M | 1.30M | -- |
| Total Debt Repaid | -1.30M | -300.00K | -300.00K | -300.00K | -- |
| Issuance of Common Stock | 47.14M | 50.61M | 32.30M | 16.59M | 19.84M |
| Repurchase of Common Stock | -61.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | 200.00 | 200.00 | 200.00 | 100.00 | -- |
| Repurchase of Preferred Stock | -200.00 | -200.00 | -200.00 | -100.00 | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -169.30K | -- | -- | -3.83M | -3.83M |
| Cash from Financing | 46.91M | 51.61M | 33.30M | 13.76M | 16.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.56M | 6.62M | 1.00M | -11.82M | -12.53M |